← Open Payments lookup

NPI 1609284249: Open Payments

NPI 1609284249. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$74 in 1 payment from 1 company in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $74

Food & beverage: $74
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.1$74

Products named: REXULTI.